Presentation Details:
Dr. Chase Cannon reviews important research abstracts from CROI 2025 that focus on treatment of Mpox, DoxyPEP, and HIV pre-exposure prophylaxis (PrEP), including potential use of a once-yearly formulation of lenacapavir for PrEP.
Presentation Transcript: